OSCP1 inhibitors constitute a class of chemicals specifically tailored to interact with the protein OSCP1, which stands for Organic Solute Carrier Partner 1. This protein plays a role in cellular processes that involve the transport of organic solutes across cellular membranes. Inhibitors targeting OSCP1 are designed to modulate the function of this transporter protein, effectively altering the transport dynamics of specific organic solutes. These molecular interactions are highly specific, with inhibitors often designed to fit the unique structural conformation of OSCP1's solute-binding site or other regulatory domains that are essential for its activity. The development of OSCP1 inhibitors is a sophisticated task that necessitates a profound understanding of the protein's structure and mechanism of action.
To create an OSCP1 inhibitor, extensive research into the protein's structure, the conformation of its solute-binding domain, and its interaction with other cellular proteins is essential. Chemical entities that can interact with these sites are then synthesized and assessed for their ability to bind to OSCP1 and impede its function. The specificity of these inhibitors is of paramount importance to avoid unintended interactions with other proteins that may have similar structural motifs or binding domains.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $146.00 $12250.00 | 18 | |
Inhibits ATP synthase by binding to the OSCP1-containing Fo sector, thereby preventing ATP synthesis. | ||||||
DCC | 538-75-0 | sc-239713 sc-239713A | 25 g 100 g | $71.00 $204.00 | 3 | |
Covalently binds to ATP synthase subunits, potentially affecting the function of OSCP1. | ||||||
Bongkrekic acid | 11076-19-0 | sc-205606 | 100 µg | $418.00 | 10 | |
Acts on the mitochondrial ADP/ATP carrier, influencing ATP synthase activity indirectly and potentially OSCP1. | ||||||
Sodium azide | 26628-22-8 | sc-208393 sc-208393B sc-208393C sc-208393D sc-208393A | 25 g 250 g 1 kg 2.5 kg 100 g | $42.00 $152.00 $385.00 $845.00 $88.00 | 8 | |
Inhibits ATP synthase, and might indirectly affect OSCP1 function. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $90.00 | 1 | |
Has been shown to reduce ATP synthase activity, possibly impacting OSCP1 indirectly. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $254.00 | 41 | |
Inhibits complex I of the electron transport chain, which can indirectly affect ATP synthase and OSCP1. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $54.00 $62.00 $1642.00 $4600.00 | 51 | |
Inhibits complex III of the electron transport chain, influencing ATP synthase activity and possibly OSCP1. | ||||||
Myxothiazol | 76706-55-3 | sc-507550 | 1 mg | $145.00 | ||
Another complex III inhibitor, can indirectly affect ATP synthase activity and OSCP1. | ||||||
Valinomycin | 2001-95-8 | sc-200991 | 25 mg | $163.00 | 3 | |
Alters mitochondrial membrane potential, affecting ATP synthase activity and possibly OSCP1. |